# SHENACARE fast continuation — 2026-10-10

## Integration and verification

Integration branch: `fix/missing-migrations`. Existing overlapping agent edits were preserved in `3264d09` before merging. Only the six actual conflicts were resolved, after checking that the closure versions incorporated the existing changes. Unrelated AI files, uploads and caches were untouched; no worktree was reset.

Merge commit: `cc0803c`. Both accepted commits (`ae8016b`, `b8b0983`) are ancestors of this integration. The integrated pipeline passed 12/12 PostgreSQL tests; TypeScript and diff checks passed.

Migration validation used two newly created disposable PostgreSQL databases. All 28 migrations deployed to a fresh database. The upgrade case deployed the 27-migration pre-closure schema, seeded a legacy supplier/customer and catalog/media/offer/price/listing, then deployed the final schema twice. Legacy customer and commercial/catalog data were unchanged. New membership defaulted to null; valid linkage worked, invalid supplier FK was rejected, and deleting a supplier revoked membership through SET NULL. No production or source pilot database migration was run.

Tests used an isolated generated Prisma client matching the final schema, via `PIPELINE_PRISMA_CLIENT`; shared generated dependencies and the running database were not regenerated/migrated. Normal rollout must apply reviewed migrations and generate the matching client before starting the updated API. No rollout was performed.

## Commerce security fix

`c53c4f7` closes anonymous price/listing operations. Price management and operational price reads require ADMIN. Listings require ADMIN or HUB_OPERATOR. Customers get current retail terms through the gated public product contract; suppliers cannot manage retail price or listings. Real session/role tests cover every command/read, denied requests with unchanged persisted state, allowed Admin/Hub operations, and malformed price input. The focused pipeline/security suite passed 13/13.

## GLO-182 and GLO-183

- `97cf85b`: GLO-182 discovery, search, brand/category/product-line filters, eligible facets/totals, grouped variants, validated cursor pagination and confirmed-stock freshness. Legacy pagination now follows eligibility filtering.
- `7a49a28`: GLO-183 detail composition, canonical SKU identity, reviewed media, independent Commerce price, availability timestamps/freshness, reviewed identity facts and public routine placement.
- `9e4a9bc`: focused follow-up ensures an incomplete sibling variant cannot be the only search match exposing its parent; the seven discovery/detail tests passed again after this correction.

Combined PostgreSQL HTTP and module-boundary verification passed 27/27 tests (13 pipeline/security, 7 discovery/detail, 7 architecture assertions). Final focused verification also covers the sibling search correction. TypeScript and git diff checks passed. No frontend changes, AI image generation, dependencies, broad audit or architecture rewrite.

No Linear specifications were supplied. Assumptions and response semantics are in `glo182-discovery-contract.md` and `glo183-product-detail-contract.md`. Confirmation freshness defaults to a configurable 24 hours. Catalog scan batches are bounded, but accurate totals/facets still evaluate the filtered catalog; optimization for a large catalog is deferred. Pagination stabilizes ordering and new insertions, while stock/price eligibility remains live and unreserved.

Structured human-approved clinical/content facts are absent from the current schema/data. Detail exposes reviewed identity facts and explicitly marks content facts unavailable; scraped research is not certified. This is a remaining functional/business limitation, not a claim of full clinical-content readiness.

## Real pilot readiness

Read-only recheck of pilot job `b191d313-c2e1-476b-814d-83221c49e748`: **0/12 genuinely sellable**, ten demo products remain quarantined/hidden, two candidates have no canonical Product. No item was promoted or given fabricated price/stock/rights/identity. Historical ingestion status `published` is not current customer visibility.

| Pilot item | Canonical record | Verified readiness |
| --- | --- | --- |
| AVE-5001 — Avene Thermal Spring Water | Existing, exact size absent | Hidden; facts/media/quote/stock/retail/operator evidence missing |
| AVE-5002 — Avene Cicalfate+ Cream | Existing, exact size absent | Hidden; same evidence missing |
| BDR-6001 — Bioderma Sensibio H2O | No canonical Product | Hidden; identity creation plus all approvals needed |
| BDR-6002 — Bioderma Atoderm Intensive Baume | Existing, exact size absent | Hidden; all approvals needed |
| CER-1001 — CeraVe Moisturizing Cream | Existing, exact size absent | Shortlisted for evidence collection; blocked |
| CER-1002 — CeraVe Hydrating Facial Cleanser | Existing, exact size absent | Hidden; all approvals needed |
| EUC-4001 — Eucerin Oil Control SPF50+ | Existing, exact size absent | Shortlisted for evidence collection; blocked |
| EUC-4002 — Eucerin DermatoCLEAN Gel | Existing, exact size absent | Hidden; all approvals needed |
| LRP-2001 — Anthelios UVMune 400 Invisible Fluid | Existing, exact size absent | Shortlisted for evidence collection; blocked |
| LRP-2002 — Effaclar Foaming Gel | No canonical Product | Hidden; identity creation plus all approvals needed |
| VIC-3001 — Minéral 89 | Existing, exact size absent | Hidden; all approvals needed |
| VIC-3002 — Normaderm Phytosolution | Existing, exact size absent | Hidden; all approvals needed |

All ten stored packshots are invalid eight-byte PNG signatures, without review receipts or media rights evidence. Supplier offers belong to the synthetic pilot supplier, have no actual quotation evidence or confirmation, and are disabled. No pilot item has a Commerce SellingPrice. All twelve lack human-reviewed product facts. Detailed candidate IDs, current records and evidence are in `glo78-pilot-evidence.json`.

### First-three evidence collection shortlist

These are candidates for verification, not verified products. Official pages were checked on 2026-10-10; product-family facts do not validate the recorded regional barcode, authorize image reuse, establish supplier stock or approve a SHENACARE price.

| Item and recorded barcode (unverified) | What official evidence supports | Exact identity input still needed |
| --- | --- | --- |
| CER-1001 / 3606000537736 | Manufacturer confirms Moisturizing Cream family, face/body use and ceramide formulation. [CeraVe](https://www.cerave.com/skincare/moisturizers/moisturizing-cream) | Package front/back/EAN and supplier catalog proving regional size/formulation. The extracted 12 oz and barcode were not established by retrieved page text; do not canonicalize them. |
| LRP-2001 / 3337875797597 | Official UK page identifies Invisible Fluid SPF50+ 50 ml, distinct from tinted variants. [La Roche-Posay](https://www.laroche-posay.co.uk/en_GB/anthelios-uvmune-400-invisible-fluid-spf50-sun-cream-for-sensitive-skin-50ml/LRP_026.html) | Regional non-tinted exact EAN/package and formulation mapping. Retrieved page text does not establish the recorded barcode. UK shop stock/price are not our supplier stock/retail approval. |
| EUC-4001 / 4005800119339 | Official international page identifies Oil Control Gel-Cream SPF50+ 50 ml, separately from SPF30/tinted versions. [Eucerin](https://int.eucerin.com/products/sun-protection/sun-gel-creme-dry-touch-spf-50plus) | Exact regional EAN/package/formula mapping; current official NART is 69767-00000-29, with no demonstrated match to recorded EAN. |

### Required inputs for each of the first three

1. Supplier legal identity and authorized account, signed/catalog-backed exact SKU/EAN/size/unit/variant/market; package photos and current ingredient/usage/warning label. Human reviewer must resolve every identity discrepancy and approve source-backed facts.
2. Real variant-correct image file or authorized supplier/manufacturer asset URL, written commercial reuse permission/license scope, source URL, exact SKU mapping and operator media review. A publicly accessible image is not a license.
3. Actual dated quotation: supplier SKU, cost amount/currency, tax treatment, MOQ, lead time, delivery market, validity period; dated exact-SKU availability/quantity confirmation. Demo costs and external shop availability do not qualify.
4. Separate Commerce decision: approved selling amount/currency, tax basis, effective/expiry dates and named authorized approver. No cost-to-retail arithmetic or foreign-shop price substitution.
5. Named operator approval of identity, facts, media and readiness, followed by explicit publication/listing only after every required condition passes. Keep Product hidden and offer unavailable until the evidence is complete.

## Remaining blockers

- P0 discovered in this slice: anonymous Commerce price/listing access, fixed in committed code. Existing running instances are not changed until an authorized rollout; no deployment was performed.
- P1 launch blocker: zero real products have the required identity/facts/media rights/supplier quotation/fresh stock/retail approval/operator evidence. The first-three target remains blocked externally.
- P1 contract limitation: approved structured content facts are unavailable; business facts review and its persistence contract need definition before exposing certified clinical/content facts.
- Release prerequisite: reviewed migration/client rollout and agreement on the provisional stock freshness policy. There is no merge or migration verification blocker.

Temporary migration-schema/test-storage scratch folders remain untracked: automatic approval review rejected cleanup as "blocked by policy". These folders contain disposable test artifacts; unrelated uploads and AI agent work were preserved.

## Security assessment

Security impact: closes retail-price/publication tampering and restricts public product composition.
Trust boundary: anonymous/customer/supplier requests versus privileged Commerce commands and public projections.
Authorization rule: ADMIN prices; ADMIN/HUB_OPERATOR listings; public products require all technical visibility gates.
Sensitive data involved: session identity, supplier cost and customer routine/profile data; none exposed in public projections.
Abuse cases considered: anonymous writes, supplier/customer/Hub privilege escalation, malformed queries, cursor filter replay, hidden sibling/media leakage and private routine exposure.
Security tests added: persisted HTTP guard checks plus negative visibility/query/privacy cases using synthetic disposable fixtures.
Remaining risk: real-world authenticity/rights require external receipts and operator decisions; deployment is pending, and this focused slice is not a system-wide security audit.
